WHO takes strict action on children deaths in Chhindwara; Issues warning about 3 syrups

WHO urged authorities to report any detection of these drugs in their countries to the health agency.

New Delhi: The World Health Organization (WHO) on Monday issued an advisory regarding contaminated cough syrups.

It urged authorities to report any detection of these drugs in their countries to the health agency.

Indeed, 23 newborns died after consuming Coldrif cough syrup in the Chhindwara district of Madhya Pradesh. Following this, several state governments in India have banned this cough syrup. The WHO has also taken cognizance of this deadly cough syrup.

WHO takes strict action against three cough syrups
The World Health Organization stated that the affected drugs are specific batches of Coldrif from Srisan Pharmaceuticals, Respifresh TR from Rednex Pharmaceuticals, and Relife from Shape Pharma.

The health agency stated that the contaminated products pose a serious risk and can cause serious, potentially fatal, illness.

What did the CDSCO tell the WHO?
Meanwhile, India's health authority, the Central Drugs Standard Control Organization, told the World Health Organization that the syrup was allegedly consumed by children under the age of five. The cough syrup reportedly contained toxic diethylene glycol at levels nearly 500 times the permissible limit.

However, the CDSCO stated that none of the contaminated medicines were exported from India and there was no evidence of illegal exports. The US Food and Drug Administration confirmed on Friday that these toxic cough syrups were not shipped to the United States